File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Conference Paper: SU‐D‐137‐03: Bayesian Belief Network Based Personalized Adaptive Decision Support to Individualize Response‐Based Adaptive Therapy

TitleSU‐D‐137‐03: Bayesian Belief Network Based Personalized Adaptive Decision Support to Individualize Response‐Based Adaptive Therapy
Authors
Issue Date2013
Citation
Medical Physics, 2013, v. 40, n. 6, p. 102 How to Cite?
AbstractPurpose: To develop a personalized adaptive decision support tool to aid in assigning tumor dose before actual dose delivery and then adjusted for individualized treatment during the course of therapy to maximize each patient's overall survival while maintaining a specified population‐based overall toxicity rate. Methods: As an example, a simple personalized adaptive decision support tool was developed based on data prospectively gathered from previously treated lung cancer patients and a Bayesian decision network which seeks an appropriate tumor dose (TD) and mean lung dose (MLD) combination for each individual patient at two time points, before the actual dose delivery AND during the course of treatment. The inputs of the decision support tool are initial/current TD and MLD; identified (via data mining) patient's specifics such as age, gross tumor volume (GTV), lung cancer staging; and then, as weighted by preferences to the outcome of radiation treatment (tradeoffs between predicted survival and potential for complications). Moreover, each patient's individual biomarkers before (IL‐8) and during the treatment (TGF‐β1) are important inputs as well. Satisfaction values associated with these scenarios are evaluated from the pair‐wise comparison based on an analytic hierarchy process, and are determined by the individualized preference during the course of treatment. Results: Each patient's local tumor control and toxicity can be predicted based on these inputs, and a decision alert/suggestion to adjust current TD and MLD based on preference for the patient under consideration is provided as the output of the system. Conclusion: Although our decision support tool is still in its infancy, it is a data‐driven, response‐based and patient‐centered approach, and it can help the physician make more efficient decision and improve the patient's therapeutic gain in the radiation treatment. R01CA142840. © 2013, American Association of Physicists in Medicine. All rights reserved.
Persistent Identifierhttp://hdl.handle.net/10722/267067
ISSN
2021 Impact Factor: 4.506
2020 SCImago Journal Rankings: 1.473
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorLuo, Y.-
dc.contributor.authorMcshan, D.-
dc.contributor.authorKong, F.-
dc.contributor.authorMatuszak, M.-
dc.contributor.authorSchipper, M.-
dc.contributor.authorTen Haken, R.-
dc.date.accessioned2019-01-31T07:20:25Z-
dc.date.available2019-01-31T07:20:25Z-
dc.date.issued2013-
dc.identifier.citationMedical Physics, 2013, v. 40, n. 6, p. 102-
dc.identifier.issn0094-2405-
dc.identifier.urihttp://hdl.handle.net/10722/267067-
dc.description.abstractPurpose: To develop a personalized adaptive decision support tool to aid in assigning tumor dose before actual dose delivery and then adjusted for individualized treatment during the course of therapy to maximize each patient's overall survival while maintaining a specified population‐based overall toxicity rate. Methods: As an example, a simple personalized adaptive decision support tool was developed based on data prospectively gathered from previously treated lung cancer patients and a Bayesian decision network which seeks an appropriate tumor dose (TD) and mean lung dose (MLD) combination for each individual patient at two time points, before the actual dose delivery AND during the course of treatment. The inputs of the decision support tool are initial/current TD and MLD; identified (via data mining) patient's specifics such as age, gross tumor volume (GTV), lung cancer staging; and then, as weighted by preferences to the outcome of radiation treatment (tradeoffs between predicted survival and potential for complications). Moreover, each patient's individual biomarkers before (IL‐8) and during the treatment (TGF‐β1) are important inputs as well. Satisfaction values associated with these scenarios are evaluated from the pair‐wise comparison based on an analytic hierarchy process, and are determined by the individualized preference during the course of treatment. Results: Each patient's local tumor control and toxicity can be predicted based on these inputs, and a decision alert/suggestion to adjust current TD and MLD based on preference for the patient under consideration is provided as the output of the system. Conclusion: Although our decision support tool is still in its infancy, it is a data‐driven, response‐based and patient‐centered approach, and it can help the physician make more efficient decision and improve the patient's therapeutic gain in the radiation treatment. R01CA142840. © 2013, American Association of Physicists in Medicine. All rights reserved.-
dc.languageeng-
dc.relation.ispartofMedical Physics-
dc.titleSU‐D‐137‐03: Bayesian Belief Network Based Personalized Adaptive Decision Support to Individualize Response‐Based Adaptive Therapy-
dc.typeConference_Paper-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1118/1.4814006-
dc.identifier.scopuseid_2-s2.0-85024824556-
dc.identifier.volume40-
dc.identifier.issue6-
dc.identifier.spage102-
dc.identifier.epage-
dc.identifier.isiWOS:000336849903038-
dc.identifier.issnl0094-2405-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats